Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver

Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver

US Patent 9868768 · Granted Jan 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipopeptides for use in treating liver diseases and cardiovascular diseases2025
Double-labeled probe for molecular imaging and use thereof2024
18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Method and means for the rapid detection of HDV infections2023
Double-labeled probe for molecular imaging and use thereof2023
Double-labeled probe for molecular imaging and use thereof2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Methylglyoxal-scavenging cyclic peptides and their use for the prevention and tr2021
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2021